Want to join the conversation?
$FITB 2Q15 Call: Non-interest expense was higher in the quarter, in line with our expectations and came in at $947MM vs. $923MM in 1Q15. The sequential increase was impacted by higher revenue base incentive compensation and long-term incentives in 2Q15 as well as an increase of $2MM in severance.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)